Onconetix, Inc.ONCOEarnings & Financial Report
Nasdaq
ONCO Q3 2025 Key Financial Metrics
Revenue
$303.7K
Gross Profit
$268.9K
Operating Profit
$-2.1M
Net Profit
$-8.8M
Gross Margin
88.6%
Operating Margin
-681.5%
Net Margin
-2892.7%
YoY Growth
-25.4%
EPS
$-6.25
Financial Flow
Onconetix, Inc. Q3 2025 Financial Summary
Onconetix, Inc. reported revenue of $303.7K for Q3 2025, with a net profit of $-8.8M (-2892.7% margin). Cost of goods sold was $34.8K, operating expenses totaled $2.3M.
Key Financial Metrics
| Total Revenue | $303.7K |
|---|---|
| Net Profit | $-8.8M |
| Gross Margin | 88.6% |
| Operating Margin | -681.5% |
| Report Period | Q3 2025 |
Onconetix, Inc. Annual Revenue by Year
Onconetix, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $2.5M).
| Year | Annual Revenue |
|---|---|
| 2024 | $2.5M |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $700433 | $704848 | $406859 | $711976 | $101630 | $106494 | $303651 |
| YoY Growth | N/A | N/A | N/A | N/A | -85.5% | -84.9% | -25.4% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|
| Assets | $75.0M | $59.5M | $61.9M | $28.2M | $18.8M | $19.1M | $19.7M |
| Liabilities | $25.3M | $24.0M | $20.9M | $18.6M | $14.3M | $12.8M | $16.3M |
| Equity | $-21.5M | $-35.8M | $33.9M | $8.5M | $4.0M | $5.9M | $3.4M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $-5.2M | $-3.2M | $-1.1M | $-917647 | $-2.0M | $-1.4M | $-3.2M |